Evidence map›Paper›PMID 22669653›Full record

ReviewNature methods2012

Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions.

Paola Picotti, Ruedi Aebersold

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature methods, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 510 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
510citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

510 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Molecular & cellular proteomics : MCP · 2018
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Comparative Proteomics of Plasma and Flagellar Membranes inInternational journal of molecular sciences · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

450 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Paola PicottiDepartment of Biology, Institute of Biochemistry, ETH Zurich, Switzerland. paola.picotti@bc.biol.ethz.ch
Ruedi Aebersold

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Selected reaction monitoring (SRM) is a targeted mass spectrometry technique that is emerging in the field of proteomics as a complement to untargeted shotgun methods. SRM is particularly useful when predetermined sets of proteins, such as those constituting cellular networks or sets of candidate biomarkers, need to be measured across multiple samples in a consistent, reproducible and quantitatively precise manner. Here we describe how SRM is applied in proteomics, review recent advances, present selected applications and provide a perspective on the future of this powerful technology.

Indexed as

BiomarkersIsotope LabelingMass SpectrometryMetabolic Networks and PathwaysPeptide FragmentsProtein Processing, Post-TranslationalProteomicsSensitivity and SpecificitySignal TransductionSystems BiologyBiomarkersPeptide Fragments

Identifiers

PMID22669653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.